Mycophenolate mofetil - Oral disease indications
You are here : Home > Formulary Search > Mycophenolate mofetil - Oral disease indications
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Shared Care
Shared Care
Shared Care
PAD Profile
ChemicalSubstance :
Mycophenolate mofetil
Indication :
Oral disease indications
Group Name :
Keywords :
Behcet's disease, refractory inflammatory oral disease, mycophenolic sodium, mycophenolic acid, RMOC, national shared care
Brand Names Include :
Arzip, CellCept, Myfortic, Myfenax, Ceptava
Important Information :
Prescribe generically (except in transplant indications)
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
6
Other Indications
Below are listed other indications that Mycophenolate mofetil is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Oral disease indications.
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol (with local adaptations) for mycophenolate mofetil and mycophenolic acid for patients within adult services (non-transplant indications)